Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebban

Showing results (291-300 of 459) with videos related to

Pageof 46
Sort By:
Hematological Oncology|April 3, 2008
Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indicationHervé Ghesquières, Céline Ferlay, Catherine Sebban, et al.
Hematological Oncology|August 14, 2012
Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patientsHervé Ghesquières, Youenn Drouet, Marie Pierre Sunyach, et al.
Cancer|August 15, 1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapyN Milpied, C Gisselbrecht, J L Harousseau, et al.
Annals of Hematology|July 8, 2009
Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survivalSana Intidhar Labidi, Christine Ménétrier-Caux, Sylvie Chabaud, et al.
Nucleic Acids Research|October 13, 2021
The horizontal transfer of Pseudomonas aeruginosa PA14 ICE PAPI-1 is controlled by a transcriptional triad between TprA, NdpA2 and MvaTGauthier Dangla-Pélissier, Nicolas Roux, Victoria Schmidt, et al.
Blood|September 1, 1994
Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic LeukemiaC Boucheix, B David, C Sebban, et al.
Leukemia & Lymphoma|January 1, 1994
Autologous BMT for post-remission therapy in adult ALL: an immunological approach. For The French Group of Therapy of Adult ALLE Racadot, C Sebban, C Boucheix, et al.
Genes, Chromosomes & Cancer|November 1, 1996
dic(4;17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disordersE Callet-Bauchu, R Rimokh, I Tigaud, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1996
Epithelial ovarian carcinoma of low malignant potentialE Darai, J Teboul, F Walker, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Pageof 46

Showing results (291-300 of 459) with videos related to

Sort By:
Pageof 46
Hematological Oncology|April 3, 2008
Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indicationHervé Ghesquières, Céline Ferlay, Catherine Sebban, et al.
Hematological Oncology|August 14, 2012
Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patientsHervé Ghesquières, Youenn Drouet, Marie Pierre Sunyach, et al.
Cancer|August 15, 1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapyN Milpied, C Gisselbrecht, J L Harousseau, et al.
Annals of Hematology|July 8, 2009
Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survivalSana Intidhar Labidi, Christine Ménétrier-Caux, Sylvie Chabaud, et al.
Nucleic Acids Research|October 13, 2021
The horizontal transfer of Pseudomonas aeruginosa PA14 ICE PAPI-1 is controlled by a transcriptional triad between TprA, NdpA2 and MvaTGauthier Dangla-Pélissier, Nicolas Roux, Victoria Schmidt, et al.
Blood|September 1, 1994
Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic LeukemiaC Boucheix, B David, C Sebban, et al.
Leukemia & Lymphoma|January 1, 1994
Autologous BMT for post-remission therapy in adult ALL: an immunological approach. For The French Group of Therapy of Adult ALLE Racadot, C Sebban, C Boucheix, et al.
Genes, Chromosomes & Cancer|November 1, 1996
dic(4;17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disordersE Callet-Bauchu, R Rimokh, I Tigaud, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1996
Epithelial ovarian carcinoma of low malignant potentialE Darai, J Teboul, F Walker, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Pageof 46